77 related articles for article (PubMed ID: 21548569)
1. Heteroatom-substituted analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid.
Xia Z; Farhana L; Correa RG; Das JK; Castro DJ; Yu J; Oshima RG; Reed JC; Fontana JA; Dawson MI
J Med Chem; 2011 Jun; 54(11):3793-816. PubMed ID: 21548569
[TBL] [Abstract][Full Text] [Related]
2. Antagonist analogue of 6-[3'-(1-adamantyl)-4'-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell-cycle arrest.
Dawson MI; Harris DL; Liu G; Hobbs PD; Lange CW; Jong L; Bruey-Sedano N; James SY; Zhang XK; Peterson VJ; Leid M; Farhana L; Rishi AK; Fontana JA
J Med Chem; 2004 Jul; 47(14):3518-36. PubMed ID: 15214780
[TBL] [Abstract][Full Text] [Related]
3. Analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid. 2. Impact of 3-chloro group replacement on inhibition of proliferation and induction of apoptosis of leukemia and cancer cell lines.
Xia Z; Correa RG; Das JK; Farhana L; Castro DJ; Yu J; Oshima RG; Fontana JA; Reed JC; Dawson MI
J Med Chem; 2012 Jan; 55(1):233-49. PubMed ID: 22136251
[TBL] [Abstract][Full Text] [Related]
4. An adamantyl-substituted retinoid-derived molecule that inhibits cancer cell growth and angiogenesis by inducing apoptosis and binds to small heterodimer partner nuclear receptor: effects of modifying its carboxylate group on apoptosis, proliferation, and protein-tyrosine phosphatase activity.
Dawson MI; Xia Z; Liu G; Ye M; Fontana JA; Farhana L; Patel BB; Arumugarajah S; Bhuiyan M; Zhang XK; Han YH; Stallcup WB; Fukushi J; Mustelin T; Tautz L; Su Y; Harris DL; Waleh N; Hobbs PD; Jong L; Chao WR; Schiff LJ; Sani BP
J Med Chem; 2007 May; 50(11):2622-39. PubMed ID: 17489579
[TBL] [Abstract][Full Text] [Related]
5. Adamantyl-substituted retinoid-derived molecules that interact with the orphan nuclear receptor small heterodimer partner: effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and inhibition of SRC homology 2 domain-containing protein tyrosine phosphatase-2 activity.
Dawson MI; Xia Z; Jiang T; Ye M; Fontana JA; Farhana L; Patel B; Xue LP; Bhuiyan M; Pellicciari R; Macchiarulo A; Nuti R; Zhang XK; Han YH; Tautz L; Hobbs PD; Jong L; Waleh N; Chao WR; Feng GS; Pang Y; Su Y
J Med Chem; 2008 Sep; 51(18):5650-62. PubMed ID: 18759424
[TBL] [Abstract][Full Text] [Related]
6. Adamantyl-substituted retinoid-related molecules induce apoptosis in human acute myelogenous leukemia cells.
Farhana L; Dawson MI; Xia Z; Aboukameel A; Xu L; Liu G; Das JK; Hatfield J; Levi E; Mohammad R; Fontana JA
Mol Cancer Ther; 2010 Nov; 9(11):2903-13. PubMed ID: 21062916
[TBL] [Abstract][Full Text] [Related]
7. Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor.
Farhana L; Dawson MI; Leid M; Wang L; Moore DD; Liu G; Xia Z; Fontana JA
Cancer Res; 2007 Jan; 67(1):318-25. PubMed ID: 17210713
[TBL] [Abstract][Full Text] [Related]
8. NF-κB p65 recruited SHP regulates PDCD5-mediated apoptosis in cancer cells.
Murshed F; Farhana L; Dawson MI; Fontana JA
Apoptosis; 2014 Mar; 19(3):506-17. PubMed ID: 24343129
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog.
Zhang Y; Dawson MI; Ning Y; Polin L; Parchment RE; Corbett T; Mohamed AN; Feng KC; Farhana L; Rishi AK; Hogge D; Leid M; Peterson VJ; Zhang XK; Mohammad R; Lu JS; Willman C; VanBuren E; Biggar S; Edelstein M; Eilender D; Fontana JA
Blood; 2003 Nov; 102(10):3743-52. PubMed ID: 12893763
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of a new series of retinoid-related biphenyl-4-ylacrylic acids endowed with antiproliferative and proapoptotic activity.
Cincinelli R; Dallavalle S; Nannei R; Carella S; De Zani D; Merlini L; Penco S; Garattini E; Giannini G; Pisano C; Vesci L; Carminati P; Zuco V; Zanchi C; Zunino F
J Med Chem; 2005 Jul; 48(15):4931-46. PubMed ID: 16033272
[TBL] [Abstract][Full Text] [Related]
11. A novel atypical retinoid endowed with proapoptotic and antitumor activity.
Cincinelli R; Dallavalle S; Merlini L; Penco S; Pisano C; Carminati P; Giannini G; Vesci L; Gaetano C; Illy B; Zuco V; Supino R; Zunino F
J Med Chem; 2003 Mar; 46(6):909-12. PubMed ID: 12620066
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic properties of Adamantyl isothiocyanate and potential in vivo metabolite adamantyl-N-acetylcystein in gynecological cancer cells.
Lange TS; Horan TC; Kim KK; Singh AP; Vorsa N; Brard L; Moore RG; Singh RK
Chem Biol Drug Des; 2012 Jan; 79(1):92-103. PubMed ID: 21974809
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
[TBL] [Abstract][Full Text] [Related]
14. SHP and Sin3A expression are essential for adamantyl-substituted retinoid-related molecule-mediated nuclear factor-kappaB activation, c-Fos/c-Jun expression, and cellular apoptosis.
Farhana L; Dawson MI; Dannenberg JH; Xu L; Fontana JA
Mol Cancer Ther; 2009 Jun; 8(6):1625-35. PubMed ID: 19509248
[TBL] [Abstract][Full Text] [Related]
15. The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism.
Di Francesco AM; Meco D; Torella AR; Barone G; D'Incalci M; Pisano C; Carminati P; Riccardi R
Biochem Pharmacol; 2007 Mar; 73(5):643-55. PubMed ID: 17150196
[TBL] [Abstract][Full Text] [Related]
16. Cellular and pharmacological bases of the antitumor activity of a novel adamantyl retinoid, ST1926.
Pisano C; Merlini L; Penco S; Carminati P; Zunino F
J Chemother; 2004 Nov; 16 Suppl 4():74-6. PubMed ID: 15688616
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo growth inhibition of cancer cells by adamantylmaleimide derivatives.
Wang JJ; Chern YT; Liu TY; Chi CW
Anticancer Drug Des; 1998 Oct; 13(7):779-96. PubMed ID: 9807162
[TBL] [Abstract][Full Text] [Related]
19. Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activity.
Valente S; Tardugno M; Conte M; Cirilli R; Perrone A; Ragno R; Simeoni S; Tramontano A; Massa S; Nebbioso A; Miceli M; Franci G; Brosch G; Altucci L; Mai A
ChemMedChem; 2011 Apr; 6(4):698-712. PubMed ID: 21374822
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of cinnamyl compounds as potent antitumor agents.
Shin DS; Kim J; Han DC; Son KH; Lee CW; Kim HM; Hong SH; Kwon BM
Bioorg Med Chem Lett; 2007 Oct; 17(19):5423-7. PubMed ID: 17683933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
